Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study Visits

Arthritis Care and Research

Volumn 51, Issue 2, 2004, Pages 258-263

  Uribe, América G ^a   Alarcón, Graciela S ^a   Sanchez, Martha L ^a   McGwin Jr , Gerald ^a   Sandoval, Robert ^b   Fessler, Barri J ^a   Bastian, Holly M ^a   Friedman, Alan W ^b   Baethge, Bruce A ^c   Reveille, John D ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Compliance; Multiethnic study; Systemic lupus erythematosus

Indexed keywords

ADULT; AFRICAN AMERICAN; AMBULATORY CARE; ARTICLE; CAUCASIAN; CHRONIC DISEASE; COHORT ANALYSIS; CONSULTATION; DISEASE ACTIVITY; DISEASE DURATION; ETHNIC GROUP; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT; PATIENT COMPLIANCE; PREDICTION; RISK FACTOR; SOCIAL ASPECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 11144353925     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20226     Document Type: Article

References (36)

1. Dunber-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res 2000;18:48-90.
2. Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, et al. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcome Study. J Behav Med 1994;17:347-60.
3. Boaventura I, Coelho R, Rocha-Goncalves F. Compliance to therapy: its importance in research and clinical practice. Rev Port Cardiol 1994;13:677-83.
4. Kruse W, Schlierf G, Weber E. Monitoring compliance in clinical trials. Lancet. 1990;335:803-4.
5. Fiester AR, Rudestam RE. A multivariate analysis of the early dropout process. J Consult Clin Psychol 1975;43:528-35.
6. Dove HG, Schneider LC. The usefulness of patients individual characteristics in predicting no-shows in outpatient clinics. Med Care 1981;19:734-40.
7. Goldman L, Freiden R, Cook EF, Eigner L, Grinch P. A multivariate approach to the prediction of no show behavior in a primary care center. Arch Intern Med 1982;142:563-7.
8. Frankel S, Farrow A, West R. Non-attendance or non-invitation: a case-control study of failed outpatient appointment. BMJ 1989;289:1343-5.
9. Melnikov J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994;9:96-105.
10. Jones PK, Jones SL, Katz J. A randomized trial to improve compliance in urinary tract infection patients in the emergency department. Ann Emerg Med 1990;19:16-20.
11. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med 1997;157:1921-9.
12. Dyer PH, Lloyd CE, Lancashire RJ, Bain SC, Barnett AH. Factors associated with clinic non-attendance in adults with type I diabetes mellitus. Diabet Med 1998;15:339-43.
13. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
14. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome: a cohort study. Lupus 2000;9:601-6.
15. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
16. Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res 2000;13:406-8.
17. Mirotznik J, Ginzler E, Zagon G, Baptiste A. Using the health belief model to explain clinic appointment-keeping for the management of a chronic disease condition. J Community Health 1998;23:195-210.
18. Gladman DD, Koh DR, Urowitz MB, Farewell VT. Lost-to-follow-up study in systemic lupus erythematosus (SLE). Lupus 2000;9:363-7.
19. Alarcón GS, Friedman AW, Straaton KV, Lisse J, Moulds JM, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 1999;8:197-209.
20. Alarcón GS, McGwin G Jr, Bartolucci AA, Roseman JM, Lisse J, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-806.
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
22. U.S. Department of Commerce, Bureau of the Census. Current population reports, Series P-23, No, 28 and Series P-60, No. 68 and subsequent years. Washington (DC): Housing and Household Economic Statistics Division; 1995.
23. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
24. Liang MH, Fortin PR, Isenberg DA, Snaith L. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda. Rheumatol Int 1991;11:133-6.
25. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
26. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
27. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26:724-32.
28. Cohen S, Mermelstein R, Kamarch T, Hoberman HN. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: theory, research and applications. Boston: Martinus Nijhoff; 1985. p. 73-94.
29. Engle EW, Callahan LF, Pincus T, Hochberg MC. Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index. Arthritis Rheum 1990;33: 281-5.
30. Pilowsky I. Dimensions of illness behavior as measured by the illness behavior questionnaire: a replication study. J Psychosom Res 1993;37:53-62.
31. Deyo RA, Inui TS. Dropouts and broken appointments: a literature review and agenda for future research. Med Care 1980;18:1146-57.
32. Gruzd DC, Shear CL, Rodney M. Determinants of no-show appointment behavior: the utility of multivariate analysis. Fam Med 1986;18:217-20.
33. U. S. Census Bureau. URL: www.census.gov/hhes/www/housing/resseg/papertoc.html. 2000.
34. Kiefe CI, Heudebert G, Box B, Farmer RM, Michael M, Clancy CM. Compliance with post-hospitalization follow-up visits: rationing by inconvenience? Ethn Dis 1999;9:387-95.
35. Pullar T, Kumar S, Feely M. Compliance in clinical trials. Ann Rheum Dis 1989;48:871-5.
36. Probstfield JL, Russell ML, Henske JC, Reardon RJ, Insull W Jr. Successful program for recovery of dropouts to a clinical trial. Am J Med 2002;80:777-84.